4107 Stock Overview
Manufactures and sells medical devices in Asia, South America, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4107 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Bioteque Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$119.50 |
| 52 Week High | NT$147.50 |
| 52 Week Low | NT$107.00 |
| Beta | 0.48 |
| 1 Month Change | -6.64% |
| 3 Month Change | -8.43% |
| 1 Year Change | 11.16% |
| 3 Year Change | 3.91% |
| 5 Year Change | -7.72% |
| Change since IPO | 357.18% |
Recent News & Updates
Recent updates
A Look At The Fair Value Of Bioteque Corporation (GTSM:4107)
Apr 26
Should You Buy Bioteque Corporation (GTSM:4107) For Its Dividend?
Mar 29Bioteque Corporation's (GTSM:4107) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 11The Trends At Bioteque (GTSM:4107) That You Should Know About
Feb 24Update: Bioteque (GTSM:4107) Stock Gained 51% In The Last Three Years
Feb 09Estimating The Intrinsic Value Of Bioteque Corporation (GTSM:4107)
Jan 25Bioteque (GTSM:4107) Has A Rock Solid Balance Sheet
Jan 10
Does Bioteque Corporation (GTSM:4107) Have A Place In Your Dividend Portfolio?
Dec 25Are Bioteque Corporation's (GTSM:4107) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Dec 10Will Bioteque (GTSM:4107) Multiply In Value Going Forward?
Nov 22Shareholder Returns
| 4107 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -1.2% | -2.0% | -2.1% |
| 1Y | 11.2% | -5.9% | 25.6% |
Return vs Industry: 4107 exceeded the TW Medical Equipment industry which returned -5.9% over the past year.
Return vs Market: 4107 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
| 4107 volatility | |
|---|---|
| 4107 Average Weekly Movement | 1.7% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4107 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4107's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | n/a | Jin-Long Lin | www.bioteq.com.tw |
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine collection bags; and IV administration products, such as PVC IV infusion bags, PVC bags, and twist-off ports.
Bioteque Corporation Fundamentals Summary
| 4107 fundamental statistics | |
|---|---|
| Market cap | NT$8.28b |
| Earnings (TTM) | NT$499.22m |
| Revenue (TTM) | NT$2.09b |
16.6x
P/E Ratio4.0x
P/S RatioIs 4107 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4107 income statement (TTM) | |
|---|---|
| Revenue | NT$2.09b |
| Cost of Revenue | NT$1.19b |
| Gross Profit | NT$901.60m |
| Other Expenses | NT$402.39m |
| Earnings | NT$499.22m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.20 |
| Gross Margin | 43.21% |
| Net Profit Margin | 23.92% |
| Debt/Equity Ratio | 14.7% |
How did 4107 perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield62%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:29 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioteque Corporation is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| Ming Hong Chu | KGI Securities Co. Ltd. |
| Hsiu Chi Lin | Masterlink Securities Corp. |